Key result
Transfemoral ACURATE neo yields favorable 1-year outcomes with greater than mild PVL in ~4%.
Why the study?
Does transfemoral implantation of the ACURATE neo transcatheter heart valve result in favorable 1-year clinical and echocardiographic outcomes in a real-world patient population?
Observational (n=1,000)
Yes
Does transfemoral implantation of the ACURATE neo transcatheter heart valve result in favorable 1-year clinical and echocardiographic outcomes in a real-world patient population?
Transfemoral implantation of the ACURATE neo transcatheter heart valve demonstrates favorable 1-year hemodynamics and low rates of paravalvular leak, mortality, and new pacemakers in a real-world European registry.
No takes yet. Share an insight, caveat, or question.
Supports ACURATE neo in real-world TAVR; extends observational data but leaves randomized comparisons open.
Kim et al. (2018) conducted an observational in Transcatheter heart valve implantation (n=1,000). ACURATE neo transcatheter heart valve was evaluated on Mean gradient and paravalvular leakage. Transfemoral implantation of the ACURATE neo prosthesis resulted in favorable 1-year outcomes, with a mean gradient of 7.3 mm Hg and greater than mild paravalvular leakage in 3.6% of patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: